Taylor JL - Search Results

1

BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity.

Keyser A, Troudt JM, Taylor JL, Izzo AA. Keyser A, et al. Among authors: taylor jl. Vaccine. 2011 Nov 21;29(50):9308-15. doi: 10.1016/j.vaccine.2011.10.019. Epub 2011 Oct 18. Vaccine. 2011. PMID: 22015391 Free PMC article.

2

Mycobacterial infection induces the secretion of high-mobility group box 1 protein.

Grover A, Taylor J, Troudt J, Keyser A, Sommersted K, Schenkel A, Izzo AA. Grover A, et al. Cell Microbiol. 2008 Jun;10(6):1390-404. doi: 10.1111/j.1462-5822.2008.01135.x. Epub 2008 Mar 5. Cell Microbiol. 2008. PMID: 18331466

3

Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.

Grover A, Taylor J, Troudt J, Keyser A, Arnett K, Izzo L, Rholl D, Izzo A. Grover A, et al. Infect Immun. 2009 Nov;77(11):4837-46. doi: 10.1128/IAI.00704-09. Epub 2009 Sep 8. Infect Immun. 2009. PMID: 19737892 Free PMC article.

4

Three protein cocktails mediate delayed-type hypersensitivity responses indistinguishable from that elicited by purified protein derivative in the guinea pig model of Mycobacterium tuberculosis infection.

Yang H, Troudt J, Grover A, Arnett K, Lucas M, Cho YS, Bielefeldt-Ohmann H, Taylor J, Izzo A, Dobos KM. Yang H, et al. Infect Immun. 2011 Feb;79(2):716-23. doi: 10.1128/IAI.00486-10. Epub 2010 Dec 6. Infect Immun. 2011. PMID: 21134965 Free PMC article.

5

Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection.

Taylor JL, Hattle JM, Dreitz SA, Troudt JM, Izzo LS, Basaraba RJ, Orme IM, Matrisian LM, Izzo AA. Taylor JL, et al. Infect Immun. 2006 Nov;74(11):6135-44. doi: 10.1128/IAI.02048-05. Epub 2006 Sep 18. Infect Immun. 2006. PMID: 16982845 Free PMC article.

6

Lack of alpha-1 integrin alters lesion morphology during pulmonary Mycobacterium tuberculosis infection.

Taylor JL, Bielefeldt-Ohmann H, Pozzi A, Izzo AA. Taylor JL, et al. Tuberculosis (Edinb). 2008 Sep;88(5):444-52. doi: 10.1016/j.tube.2008.05.006. Epub 2008 Jul 18. Tuberculosis (Edinb). 2008. PMID: 18639492 Free PMC article.

7

HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule.

Taylor JL, Wieczorek A, Keyser AR, Grover A, Flinkstrom R, Karls RK, Bielefeldt-Ohmann H, Dobos KM, Izzo AA. Taylor JL, et al. Immunol Cell Biol. 2012 Nov;90(10):945-54. doi: 10.1038/icb.2012.34. Epub 2012 Jul 17. Immunol Cell Biol. 2012. PMID: 22801575 Free PMC article.

8

HspX vaccination and role in virulence in the guinea pig model of tuberculosis.

Wieczorek AE, Troudt JL, Knabenbauer P, Taylor J, Pavlicek RL, Karls R, Hess A, Davidson RM, Strong M, Bielefeldt-Ohmann H, Izzo AA, Dobos KM. Wieczorek AE, et al. Among authors: taylor j. Pathog Dis. 2014 Aug;71(3):315-25. doi: 10.1111/2049-632X.12147. Epub 2014 Feb 24. Pathog Dis. 2014. PMID: 24616427 Free PMC article.

9

Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA.

Taylor JL, Ordway DJ, Troudt J, Gonzalez-Juarrero M, Basaraba RJ, Orme IM. Taylor JL, et al. Infect Immun. 2005 Aug;73(8):5189-93. doi: 10.1128/IAI.73.8.5189-5193.2005. Infect Immun. 2005. PMID: 16041037 Free PMC article.

10

Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

Taylor JL, Turner OC, Basaraba RJ, Belisle JT, Huygen K, Orme IM. Taylor JL, et al. Infect Immun. 2003 Apr;71(4):2192-8. doi: 10.1128/IAI.71.4.2192-2198.2003. Infect Immun. 2003. PMID: 12654841 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,106 results

Search Page

Filters